NetworkNewsBreaks – FinCanna Capital Corp. (CSE:
Post# of 30

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, this morning announced that it has advanced the initial tranche of capital totaling $1.25 million to its investee company, Refined Resin Technologies Inc. As key milestones are realized over the next few months, the company will continue advancing a series of tranches of capital to Refined Resin in accordance with the terms of the previously announced royalty agreement between the companies. The capital paid to Refined Resin will be used toward implementing its three-phase development strategy comprised of a facility design phase, build-out phase and pre-commercial production phase. “We are very pleased to initiate funding of Refined Resin’s highly detailed three phase development strategy that will culminate in full commercialization,” FinCanna Capital president and CEO Andriyko Herchak stated in the news release. “Refined Resin’s principals have extensive experience in extraction, manufacturing, business operations and marketing that has been evident in their ability to articulate a thorough development plan identified in this release. We believe they have the capabilities to launch and grow a highly lucrative business that will deliver substantial value to our shareholders.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

